Results 261 to 270 of about 3,750,719 (375)

Patterns of Acute Gamma‐Hydroxybutyrate Harms Requiring Ambulance Attendance: Should Greater Focus Be on Regional Areas?

open access: yesDrug and Alcohol Review, EarlyView.
ABSTRACT Introduction Gamma‐hydroxybutyrate (GHB) use and attributable harms have been increasing in Europe and Australia. However, there are limited population surveillance tools available to map and track acute GHB‐related harms, particularly outside metropolitan areas. The present study examined GHB‐related ambulance attendances from January 2015 to
Naomi Beard   +5 more
wiley   +1 more source

Ethnopharmacological Perspective for Treatment of Epilepsy: An Updated Review. [PDF]

open access: yesScientifica (Cairo)
Kalra S   +8 more
europepmc   +1 more source

Polymicrogyria in infants with symptomatic congenital cytomegalovirus at birth is associated with epilepsy: A retrospective, descriptive cohort study

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
In children with symptomatic congential CMV, those with polymicrogyria are at an increased risk of developing epilepsy. Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16263 Abstract Aim To identify neonatal magnetic resonance imaging (MRI) features that predict the likelihood of children with congenital cytomegalovirus (cCMV ...
George Lawson   +7 more
wiley   +1 more source

Safety and effectiveness of stiripentol in patients with Dravet syndrome: A prospective, 3‐year, postmarketing surveillance study

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16285 Abstract Aim To conduct a postmarketing surveillance study of patients with Dravet syndrome in Japan to investigate the safety and effectiveness of long‐term, real‐world, clinical use of stiripentol (STP).
Yuki Kitamura   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy